Phibro Animal Health (PAHC) Misses Q2 EPS by 2c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky weekÂ
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Phibro Animal Health Corporation Reports Second Quarter Results
February 6, 2019 4:25 PM ESTTEANECK, N.J., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its second quarter ended December 31, 2018.
Highlights for the December 2018 quarter (compared to the December 2017 quarter)
Net sales of $218 million, an increase of $12 million, or 6%Net income of $15 million, an increase of $8 millionDiluted EPS of $0.36, an increase of $0.19Adjusted EBITDA of $32 million, a decline of $0.9 million, or 3%Adjusted diluted EPS of $0.41, a decrease of $0.03, or 7%COMMENTARY
... More


